Client: U.K Department of Health and Social Care
Duration: 2020-2025
Region: Asia and the Pacific
Country: Bangladesh
Solutions: Global Health
The Fleming Fund is a U.K. Department of Health and Social Care program administered through Mott Macdonald to help low- and middle-income countries fight antimicrobial resistance (AMR).
AMR is a leading cause of death globally, research shows that 1.27 million deaths annually are attributable to drug resistance, higher than HIV/AIDS or malaria. DAI’s Fleming Fund program in Bangladesh is a collaboration with the Bangladesh government to strengthen systems using a “One Health” approach—a multisectoral approach to complex health problems that reaches across human health, animal health, and environment sectors. As a global leader in the approach, DAI helps incorporate One Health across program interventions, supporting Bangladesh to become a leader in combating AMR and a model for better management of antimicrobials in human and animal populations.
In Bangladesh, Phase I focused on enhancing laboratory infrastructure, strengthening human resources, improving the AMR and antimicrobial use (AMU) surveillance system, building foundations for using AMR data and promoting the rational use of antimicrobial medicines. Phase II is building on this work to achieve four outcomes: producing high-quality AMR, AMU, antimicrobial consumption, and burden data; developing high-quality analyses of data; sharing the analyses and data with relevant decision-makers; and promoting sustainable investment to counter AMR.
RELATED CONTENT:
The Global Evaluation Framework Agreement 2 ensured the provision of efficient and effective expert services for the design and implementation of evaluations.
Read More